Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues

Not Applicable

Recruiting

• Conditions: Outpatient Prescription Issues
• Interventions: Other: outpatient prescription issues

• Registration Number: NCT06222424
• Lead Sponsor: Methodist Health System

Brief Summary

The study aims to document the utility of Methodist Charlton Medical Center (MCMC's)Emergency Medicine Pharmacist (EMP) Collaborative Practice Agreement (CPA )utilization for the resolution of outpatient prescription issues. Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.

Detailed Description

Use of an EMP CPA, which allows for broad prescriptive authority, will assist Emergency Department (ED )workflow by preventing a significant volume of new prescriptions needing to be sent by physician and mid-level providers. Will improve rates of ED re-visits. In addition, this Collaborative Practice Agreement (CPA) will not be associated with a large volume of new prescription errors.

Study Timeline

• Study Start: 2023-12-15
• Study First Submitted: 2024-01-16
• Study First Submitted QC: 2024-01-16
• Study First Posted: 2024-01-24
• Status Verified: 2024-10
• Last Update Submitted: 2024-11-14
• Last Update Posted: 2024-11-18
• Primary Completion: 2026-12-15
• Study Completion: 2026-12-15

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

• Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 and a progress note and documenting the reason for the call and action taken by the EMP.

Exclusion Criteria

• CPA actions were misclassified as discharge prescription issue resolutions.
• Patients with prescriptions pursuant to late culture review, formulation changes not requiring a new prescription, prescription transfers to another pharmacy, or simple retransmission of prescriptions.
• Patients documented to have left the ED against medical advice.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023	outpatient prescription issues	Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.

Primary Outcome Measures

Name	Time	Method
Number of prescriptions and medication types sent to outpatient pharmacies	2 years	Number of prescriptions and medication types sent to outpatient pharmacies by EMPs pursuant to outpatient prescription issue resolution.

Secondary Outcome Measures

Name	Time	Method
Number of patients returning with complaint or diagnosis related to EMP generated prescriptions	2 years	Proportion of patients returning with a complaint or diagnosis related to index EMP-generated prescriptions at three and six-month time points

Trial Locations

Locations (1)

Clinical Research Institute at Methodist Health System; 🇺🇸 Dallas, Texas, United States